Amar Rawal, MD
Urology · Marion, ILNPI 1538591268
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Boston Scientific at 44.3% of the total. Reporting peaked in 2019 at $4,490 and has fallen 93.5% since, to $291 in 2025.
Across 163 payments — averaging $58.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Coloplast$3K
- Procept Biorobotics Corporation$492
- Endo Pharmaceuticals Inc.$375
- Teleflex LLC$279
- Intuitive Surgical$222
- plus $1K from 21 others
What the payments were for
- Travel & lodging$5,38856%
- Food & beverage$3,86040%
- Education$3043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 43 | $4,236 |
| Coloplast | 33 | $2,719 |
| Procept Biorobotics Corporation | 5 | $492 |
| Endo Pharmaceuticals Inc. | 14 | $375 |
| Teleflex LLC | 15 | $279 |
| Intuitive Surgical | 2 | $222 |
| Johnson & Johnson(2 entities) | 3 | $212 |
| Astellas Pharma US Inc | 11 | $189 |
| Olympus America Inc. | 3 | $128 |
| Neotract Inc. | 5 | $107 |
| Calyxo, Inc. | 1 | $83 |
| Laborie Medical Technologies Corp. | 5 | $61 |
| SRS Medical Systems, Inc. | 1 | $55 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $54 |
| Baxter Healthcare | 3 | $54 |
| Antares Pharma, Inc. | 3 | $49 |
| Telix Pharmaceuticals | 2 | $42 |
| Medtronic | 1 | $33 |
| Bayer | 2 | $30 |
| Endo USA, Inc. | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $20 |
| Pfizer | 1 | $19 |
| Urovant Sciences Inc | 1 | $17 |
| BD | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$2,240
- GENERAL FEMALE SUI$1,669
- AMS$840
- AMS 700 CXR RTE KIT$492
- AquaBeam Robotic System$386
- UPHOLD LITE$258
- Da Vinci Surgical System$216
- XIAFLEX$150
- VASCULAR$143
How this compares
$9,552 in reported general payments places this provider in the 80th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 32 | $514 |
| Tamsulosin Hcl | 33 | $366 |
| Oxybutynin Chloride | 16 | $122 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $51 |
| Ciprofloxacin Hcl | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Other urology in Marion
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.